(NASDAQ: SEER) Seer's forecast annual revenue growth rate of 16% is not forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 38.62%, and while it is forecast to beat the US market's average forecast revenue growth rate of 13.78%.
Seer's revenue in 2026 is $16,578,000.On average, 3 Wall Street analysts forecast SEER's revenue for 2026 to be $955,316,512, with the lowest SEER revenue forecast at $917,853,119, and the highest SEER revenue forecast at $983,414,056. On average, 3 Wall Street analysts forecast SEER's revenue for 2027 to be $1,202,778,017, with the lowest SEER revenue forecast at $1,155,610,252, and the highest SEER revenue forecast at $1,238,153,842.
In 2028, SEER is forecast to generate $1,461,749,361 in revenue, with the lowest revenue forecast at $1,404,425,857 and the highest revenue forecast at $1,504,741,989.